Terminated PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT06135064

Ultrasonic Neuromodulation for Treatment of PTSD

Deep Brain Therapy With Low-intensity Ultrasound for Treatment of Post-traumatic Stress Disorder

Sponsor: University of Utah

Conditions PTSD

Interventions Diadem

Updated 5 times since 2023 Last updated: May 20, 2025 Started: Apr 5, 2024 Primary completion: Sep 27, 2024 Completion: Sep 27, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

IRB administrative closure

Other terminated trials from University of Utah

See all terminations from University of Utah

A PHASE1/PHASE2 clinical study on PTSD, this trial is terminated or withdrawn. The trial is conducted by University of Utah and has accumulated 5 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Jun 2025 — Present [monthly]

Terminated PHASE1/PHASE2

Status: Suspended → Terminated
May 2025 — Jun 2025 [monthly]

Suspended PHASE1/PHASE2

Status: Recruiting → Suspended
Sep 2024 — May 2025 [monthly]

Recruiting PHASE1/PHASE2

Status: Not Yet Recruiting → Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Dec 2023 — Jul 2024 [monthly]

Not Yet Recruiting PHASE1_PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Utah

Data source: University of Utah

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Salt Lake City, United States